HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
Nakaraang pagsara
$1.23
Sakop ng taon
$0.87 - $2.74
Market cap
45.55M USD
Average na Volume
450.71K
P/E ratio
-
Dividend yield
-
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 9.36M | 123.49% |
Net na kita | -8.90M | -225.41% |
Net profit margin | — | — |
Kita sa bawat share | -0.27 | -145.45% |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 10.89M | 25.33% |
Kabuuang asset | 11.78M | 27.47% |
Kabuuang sagutin | 11.74M | 53.99% |
Kabuuang equity | 41.67K | — |
Natitirang share | 37.03M | — |
Presyo para makapag-book | ∞ | — |
Return on assets | -205.03% | — |
Return on capital | -1,194.50% | — |
Cash Flow
Net change in cash
| (USD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -8.90M | -225.41% |
Cash mula sa mga operasyon | -3.49M | 1.08% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 4.23M | 575.60% |
Net change in cash | 747.21K | 125.87% |
Malayang cash flow | -217.86K | 89.99% |
Tungkol
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Itinatag
2018
Headquarters
Website
Mga Empleyado
13
